Canaccord raises Natera target to USD 500 for Natera stock

Published on 10/23/2026 at 11:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Canaccord set a USD 500 target on October 19, 2026. Natera stock costs EUR 362.20 on October 23, 2026, with USD 752.75 million revenue in the second quarter.

Natera's October milestones

Canaccord raised its Natera target to USD 500 on October 19, 2026.
Natera reported USD 752.75 million in second-quarter revenue for 2026.
Natera stock was trading at EUR 362.20 at 11:30 a.m. CEST at Lang & Schwarz on October 23, 2026.
Natera had a USD 57.9 billion market capitalization as of October 22, 2026.

NTRA, US6323071042, Illustration mit AI erstellt.

Natera (ISIN US6323071042) was trading at EUR 362.20 at Lang & Schwarz on October 23, 2026 at 11:30 a.m. CEST. Markets Insider reported on October 19, 2026 that Canaccord raised its Natera target from USD 375 to USD 500 and kept a Buy rating.

Why the target matters

Canaccord's revised target arrived ahead of Natera's third-quarter results and points to the importance of continued revenue expansion. The company generated USD 752.75 million in revenue in the second quarter of 2026, up 37.70 percent from the same period a year earlier, according to MarketBeat. The quarter also produced a diluted loss of USD 0.47 per share, compared with consensus of a USD 0.49 loss.

Three recent company milestones

Natera announced on October 7, 2026 that the first patients had enrolled in a Signatera-guided melanoma trial sponsored by NYU Langone Health, as reported by Natera. On October 9, 2026, the FDA granted Breakthrough Device designation to Natera's multi-cancer early detection assay, which evaluates data across 12 cancer types, according to Natera. Canaccord's USD 500 target followed on October 19, 2026.

What dates matter next?

Natera's technology is scheduled for presentation in 20 abstracts at the European Society for Medical Oncology congress from October 23 through October 26, 2026, according to Business Wire. The next quarterly results date is November 5, 2026, as shown on the company's investor-relations topic page.

Valuation stays demanding

Natera had a USD 57.9 billion market capitalization as of October 22, 2026. Its primary listing is on Nasdaq, where the 52-week range was USD 181.00 to USD 437.41 on the same date. The range places the latest US close below the year's high, while the German euro quotation remains the central reference for investors trading through Lang & Schwarz.

The stock's investment case now rests on whether fast top-line growth can narrow the quarterly loss. The second-quarter operating margin was minus 10.00 percent, making profitability the key counterweight to the raised target.

Euro quotation on October 23

Natera was trading at EUR 362.20 at Lang & Schwarz on October 23, 2026 at 11:30 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Natera stock.